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Abstract: Retinal degeneration is characterized by the dysfunction of retinal cells. Oxidative and
endoplasmic reticulum (ER) stress play an important role in the pathogenesis and progression of
retinal degeneration. Tauroursodeoxycholic acid (TUDCA) has been demonstrated to have protective
effects in in vitro and in vivo retinal degeneration models. To fully understand the molecular
mechanisms of TUDCA’s protection, we first treated human retinal pigment epithelial (RPE) cells,
ARPE-19, with H2O2 or H2O2 plus TUDCA for 24 h. RPE cells co-exposed to TUDCA had higher cell
viability and lower cell death rate compared to cells exposed to H2O2 alone. TUDCA significantly
increased antioxidant capacity in H2O2-treated RPE cells by decreasing the generation of reactive
oxygen species (ROS) and Malondialdehyde (MDA), upregulating the expression of antioxidant
genes, and increasing the generation of glutathione (GSH). TUDCA also inhibited inflammation in
H2O2-challenged RPE cells by decreasing the expression of proinflammatory cytokines. Furthermore,
TUDCA suppressed thapsigargin-induced ER stress in RPE cells, as demonstrated by decreased
the expression of CCAAT-enhancer-binding protein homologous protein (CHOP) and apoptosis.
Our present study suggests that TUDCA can protect RPE cells against oxidative damage, inflammation,
and ER stress and may benefit patients with retinal degeneration.
Keywords: tauroursodeoxycholic acid; retinal pigment epithelial cell; oxidative stress; endoplasmic
reticulum stress; protection
1. Introduction
The retinal pigment epithelium (RPE) is a hexagonal monolayer of highly specialized cells that lie
between the neurosensory retina and the choroid. The RPE is responsible for maintaining photoreceptor
function by absorbing scattered light, providing nutrition, removing metabolic waste, maintaining
the visual cycle, phagocytosing the shed outer segments of photoreceptors, and secreting a range of
functional mediators [1]. Due to continuous light absorption, high metabolic activity, and phagocytosis
of photo-oxidized outer segments, the RPE has a high level of oxidative stress. The RPE has developed
an antioxidant defense system to maintain normal function under physiological conditions. With aging
or in disease states, increased oxidative stress causes RPE dysfunction, which contributes to the
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progression of retinal degeneration, such as that present in age-related macular degeneration (AMD) [2].
Oxidative stress targeted therapy is recommended as one option for treating retinal diseases.
Tauroursodexycholic acid (TUDCA), a taurine-conjugated bile acid, is presented at a very low level
in human bile, but at a high level in bear bile [3]. Bear bile, as traditional Chinese medicine, has been used
for over three thousand years to treat a variety of diseases, including visual impairments [4,5]. In the last
15 years, many studies have provided evidence showing the protective effects of TUDCA against retinal
degeneration in retinal cell lines and animal models [6]. TUDCA treatment ameliorates photoreceptor
death in naturally occurring, knockout, and transgenic rodent models of retinal diseases [3,7–11].
TUDCA also shows the protection of ganglion cells from n-methyl-d-aspartate-induced retinal damage
in rats [12] and a rat model involving crushed optic nerve [13]. Recently, we have examined the
protective effect of TUDCA against photoreceptor degeneration in a retinitis pigmentosa GTPase
regulator (Rpgr) knockout mouse model of retinitis pigmentosa. We found that TUDCA attenuated
caspase-dependent photoreceptor cell death, inhibited retinal microglial activation, and suppressed
inflammasome formation [14].
In the current study, we have evaluated the protective potential of TUDCA against oxidative
damage and endoplasmic reticulum (ER) stress in human RPE cells. We found that TUDCA attenuated
H2O2-evoked oxidative damage and inhibited thapsigargin (TG)-induced ER stress.
2. Materials and Methods
2.1. Cell Viability
ARPE-19 cells (ATCC® CRL-2302™) were cultured in T25 flasks with DMEM/F12 medium for 24 h
in a 5% CO2 incubator at 37 ◦C. The cells were detached and seeded in 96-well plates (5 × 104 cells/well)
for 24 h then treated with H2O2, TG, TUDCA, H2O2 plus TUDCA, or TG plus TUDCA for 24 h. H2O2,
at a concentration of 750 µM, was chosen for this study, based on our previous publication [15,16]; and
1 µM TG (Cat. T9033, Sigma, Dorset, UK) is commonly used to induce ER stress in vitro [17–19]—so
we also used a dose of 1 µM for this study. TUDCA (Cat. 580549, Sigma, Dorset, UK) at different
concentrations were used. Cell viability was evaluated using an MTT assay (Cat. M2128, Sigma,
Dorset, UK) following the manufacturer’s protocol and percentage viability calculated according to
our previous description [15].
2.2. Detection of Apoptosis
Cell death was detected using DeadEnd™ fluorometric terminal deoxynucleotidyl transferase
dUTP nick end labeling (TUNEL) assay kit (Cat. G7360, Promega, Southampton, UK) according to the
manufacturer’s guidance. Briefly, ARPE-19 cells were seeded on coverslips in DMEM/F12 medium in
a 6-well plate (5 × 105/well) for 24 h. The cells were subjected to treatment with H2O2 (750 µM) or
H2O2 (750 µM) plus TUDCA (100 µM) for 24 h, then washed twice with phosphate-buffered saline
(PBS) and fixed with 4% (w/v) paraformaldehyde for 25 min, followed by washing with PBS and
permeabilizing with PBS containing 0.2% (v/v) Triton X-100. Cells were incubated with rTDT reaction
mix, and the reaction was stopped with the saline-sodium citrate (SSC) buffer (2×). Cells were mounted
with 4′,6-diamidino-2-phenylindole (DAPI) (Cat. D9542, Sigma, Dorset, UK) and FluorSave™ reagent
(Cat. 345789, Merck Millipore, Watford, UK). Quantification of cell death was performed by counting
the number of TUNEL positive cells using a ZEISS LSM 800 confocal microscope.
2.3. Quantification of Reactive Oxygen Species (ROS) Production
ARPE-19 cells (5 × 104/well) were seeded in 96-well plates and incubated for 24 h. ARPE-19 cells
were exposed to H2O2 (750 µM) or H2O2 (750 µM) plus TUDCA (100 µM) for 24 h. 6-Carboxy-20,
70-Dichlorofluorescin diacetate (DCFH-DA) (Cat. 4091-99-0, Sigma, Dorset, UK) was used to detect
total ROS as described previously [15].
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2.4. Quantitative Real-time Polymerase Chain Reaction (qRT-PCR)
ARPE-19 cells were seeded in DMEM/F12 medium in a 6-well plate (5 × 105/well) for 24 h then
incubated with H2O2 (750 µM) or H2O2 (750 µM) plus TUDCA (100 µM) for 24 h. The media
were removed, and the cells were washed with PBS twice. Total RNA was extracted using
Trizol Reagent (Cat. 93289, Sigma, Dorset, UK), and cDNA was synthesized using High-Capacity
cDNA Reverse Transcription Kit (Cat. 4368814, Thermo Fisher Scientific, Paisley, UK), following
manufacturers’ protocols. Targeted gene expression was detected using a Platinum® SYBR® Green
QPCR SuperMix-UDG w/ROX kit following manufacturer guidelines (Cat. 4309155, Thermo Fisher
Scientific, Paisley, UK). The relative gene expression was determined by a 2−∆∆CT formula. The primers
for qRT-PCR are listed in Supplementary Table S1.
2.5. Biochemical Assays
ARPE-19 cells were seeded in DMEM/F12 medium in a 6-well plate (5 × 105/well) for 24 h and
then treated with H2O2 (750 µM) or H2O2 (750 µM) plus TUDCA (100 µM) for 24 h. The medium was
discarded, the cells were scraped and homogenized in cold PBS. The cell lysates were centrifuged
for 10 min at 12,000× g, and the supernatants were collected. Catalase (CAT) and superoxide
dismutase (SOD) activities were measured using, respectively, the OxiSelect Catalase Activity Assay
Kit (Cat. STA-341, Cell Biolabs, San Diego, CA, USA) and the OxiSelect Superoxide Dismutase
Activity Assay Kit (Cat. STA-340, Cell Biolabs, San Diego, CA, USA), according to the manufacturers’
instructions. Malondialdehyde (MDA) and Glutathione (GSH) levels were measured using, respectively,
the TBARS assay kit (Cat. STA-330, Cell Biolabs, San Diego, CA, USA) and GSSG/GSH assay kit
(Cat. STA-312, Cell Biolabs, San Diego, CA, USA), following the manufacturers’ guidelines.
2.6. Measurement of Caspase-3/7 Activities
ARPE-19 cells (5 × 104/well) were cultured in a 96-well plate for 24 h and then exposed to H2O2
(750 µM) or H2O2 (750 µM) plus TUDCA (100 µM) overnight. Caspase-3 and -7 activities were
measured with a Caspase-Glo 3/7 assay kit (Cat. G8090, Promega, Southampton, UK) following the
manufacturer’s guidelines.
2.7. Enzyme-linked Immunosorbent Assay (ELISA)
ARPE-19 cells were seeded in DMEM/F12 medium in a 6-well plate (5 × 105/well) for 24 h,
then subjected to treatment with H2O2 (750 µM) or H2O2 (750 µM) plus TUDCA (100 µM) for 24 h.
The culture media were collected. Human Interleukin 1 beta (IL-1β) mini ABTS ELISA Development Kit
(Cat. 900-M95), IL-6 mini ABTS ELISA Development Kit (Cat. 900-M16), and tumor necrosis factor alpha
(TNF-α) mini ABTS ELISA Development Kit (Cat. 900-M25), all purchased from PeproTech, London,
UK, were used to measure, respectively, IL-1β, IL-6, and TNF-α, based on the manufacturer’s protocols.
2.8. Statistical Analysis
For statistical analysis, data were analyzed using one-way Anova followed by Bonferroni post-hoc
test (GraphPad Prism 6 software, version 6.0, GarphPad Software Inc., San Diego, CA, USA). All data
were obtained after at least three independent experiments.
3. Results
3.1. Effects of H2O2 and TUDCA on Cell Viability
To examine the effect of TUDCA on cell viability, we exposed ARPE-19 cells to TUDCA at different
concentrations (25, 50, 75, 100, 200, and 500 µM) and found that doses of 25, 50, 75, and 100 µM
caused no difference in cell viability between control and treated cells. However, treatment with
TUDCA at concentrations of 200 or 500 µM resulted in markedly decreased cell viability compared to
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that of control cells (Figure 1A). Consequently, TUDCA at 100 µM was used in further experiments.
When cells were treated with H2O2 (750 µM) or H2O2 (750 µM) plus TUDCA (100 µM), similar to
our previous findings of H2O2-induced effects [15,16], 750 µM H2O2 caused a marked decrease in cell
viability compared to control cells, while co-treatment with H2O2 and TUDCA significantly increased
cell viability compared to cells exposed to H2O2 alone (Figure 1B). To examine whether decreased cell
viability was due to cell death, TUNEL assay was applied to detect apoptotic cells in control, H2O2,
and H2O2-plus-TUDCA-treated cells. Cells incubated with H2O2 had a significant increase in cell
death compared to control cells, while cells co-treated with H2O2 and TUDCA exhibited significantly
decreased cell death compared to cells exposed to H2O2 alone (Figure 1C,D). In addition, we examined
caspase 3 expressions and caspase 3 and 7 activities. H2O2 treatment upregulated caspase expression
and increased activities of caspase 3 and 7 compared to control cells, while co-treatment with TUDCA
significantly lowered caspase expression and activities of caspase 3 and 7 compared to cells exposed to
H2O2 alone (Figure 2).
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Cells treated with DNase I (3000 U/mL) for 10 min were used as positive controls while the 
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Figure 1. Tauroursodeoxycholic acid (TUDCA) counteracted 2O2-induced decrease in cell viability
and increased in apoptotic cell death. (A) Cells ere treated ith TUDCA at different concentrations;
higher concentrations (200 and 500 µ ) caused significantly decreased cell viability, co pared to the
untreated (UT) control. (B) H2O2 treatment led to markedly decreased cell viability relative to control,
while co-treatment with TUDCA significantly increased cell viability relative to H2O2 treatment alone.
(C) Cell death was detected by the DeadEnd™ fluorometric terminal deoxynucleotidyl transferase
dUTP nick end labeling (TUNEL) assay in untreated (UT), H2O2, and H2O2-plus-TUDCA-treated cells.
Cells treated with DNase I (3000 U/mL) for 10 min were used as positive controls while the recombinant
terminal deoxynucleotidyl transferase (rTdT) enzyme was excluded in the negative control subjects
from the TUNEL reaction mixture. Nuclei were labeled with 4′,6-diamidino-2-phenylindole (DAPI)
(scale bar, 10 µM) (D) Quantification of dead cells in control and treated cells. Data are shown as mean
± SEM. @@@@ p < 0.0001, TUDCA (200, 500 µM) vs. untreated (UT) control; *** p < 0.001, **** p < 0.0001,
750 µM H2O2 vs. UT; # p < 0.05, #### p < 0.0001, 750 µM H2O2 plus TUDCA vs. 750 µM H2O2; ns,
no significance, TUDCA (25, 50, 75, 100 µM) vs. UT.
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Figure 2. TUDCA decreases oxidative stress-induced caspase 3 expression and caspase 3/7 activity
in ARPE-19 cells. (A) Caspase 3 mRNA in control (UT), H2O2, and H2O2-plus-TUDCA-treated
cells were measured by qRT-PCR. (B) Activities of caspase 3 and 7 in control (UT), H2O2,
and H2O2-plus-TUDCA-treated cells were measured using CASPASE-Glo 3/7 assay. Data were
presented as mean ± SEM. ** p < 0.01 and **** p < 0.0001, 750 µM H2O2 vs. untreated (UT) control;
## p < 0.01, #### p < 0.0001, 750 µM H2O2 plus TUDCA vs. 750 µM H2O2.
3.2. TUDCA Attenuated 2O2-induced Oxidative Stress in RPE Cells
ur previous work showed that exposure of RPE cells to H2O2 resulted in oxidative stress [15,16].
In the current study, we examined whether TUDCA could reduce the H2O2-induced ROS production
in ARPE-19 cells. DCFH-DA was used to determine total intracellular ROS, and the results showed
that H2O2 treated cells had a markedly high level of ROS compared to control cells; co-treatment
with TUDCA resulted in a significant decrease in ROS production compared to cells incubated with
H2O2 only (Figure 3A). We further investigated intracellular antioxidant capacity in control, H2O2,
and H2O2-plus-TUDCA-treated cells by measuring antioxidant gene expression. qRT-PCR data showed
that cells treated with H2O2 had significantly reduced expression of antioxidant genes compared to that
of control cells; co-treatment with TUDCA significantly increased the expression of these antioxidant
genes compared to cells exposed to H2O2 alone (Figure 3B–F). Additionally, we evaluated the effects of
TUDCA on SOD and CAT activities. H2O2 incubation significa tly lowered SOD and CAT activities
compared to control cells; co-incubation with TUDCA significantly increased SOD and CAT activities
compared to cells treated with H2O2 alone (Figure 4A,B).
Glutathione (GSH) plays an important role in reducing the oxidative damage in cells. We measured
GSH levels in control, H2O2, and H2O2-plus-TUDCA-treated cells and found that GSH level was
significantly decreased in H2O2-treated cells compared to control cells; the level of GSH in co-treated
cells was significantly increased compared to cells treated with H2O2 only (Figure 4C). We also examined
the level of malondialdehyde (MDA), a marker for oxidative stress, and found that cells incubated with
H2O2 showed a significant increase in MDA compared to control cells; cells co-incubated with TUDCA
exhibited a significant decrease in MDA compared to cells treated with H2O2 alone (Figure 4D).
The nuclear factor erythroid 2–related factor 2 (NRF2) plays an important defensive role against
oxidative stress by upregulating antioxidant gene expression [20]. We used qRT-PCR to measure NRF2
in control and treated cells. Cells exposed to H2O2 had a significant decrease in NRF2 compared to
control cells; in cells treated with TUDCA plus H2O2, NRF2 was significantly increased compared to
that of cells treated with H2O2 only (Figure S1).
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3.3. TUDCA Inhibited H2O2-Induced Expression of Proinflammatory Cytokines in RPE Cells
Inflammation has been implicated in the pathogenesis of inherited and complex retinal diseases [21].
There is a strong interrelationship between oxidative stress and inflammation [22]. We examined
mRNA levels of IL-1β, IL-6, and TNF-α by qRT-PCR and showed that H2O2 exposure significantly
increased IL-1β, IL-6, and TNF-α expression compared to that of control cells; co-exposure to TUDCA
markedly lowered expression of IL-1β, Il-6 and TNF-α compared to cells exposed to H2O2 alone
(Figure 5A). We also detected IL-1β, IL-6, and TNF-α protein by ELISA. The three cytokines were
significantly increased in H2O2-treated cells compared to control cells. However, co-treatment with
TUDCA significantly counteracted these H2O2-induced changes (Figure 5B).
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3.4. TUDCA Attenuated Thapsigargin-induced ER Stress in RPE Cells 
ER stress has been widely considered to be associated with the pathogenesis of retinal 
degeneration [11]. We examined whether TUDCA suppresses ER stress in RPE cells. We incubated 
ARPE-19 cells with a widely used ER stress inducer, thapsigargin (TG, 1 µM), or TG plus TUDCA. 
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Figure 5. TUDCA suppressed H2O2-induced inflammation. (A) IL-1β, IL-6, and TNF-α mRNA
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3.4. TUDCA Attenuated Thapsigargin-Induced ER Stress in RPE Cells
ER stress has been widely considered to be associated with the pathogenesis of retinal
degeneration [11]. We examined whether TUDCA suppresses ER stress in RPE cells. We incubated
ARPE-19 cells with a widely used ER stress inducer, thapsigargin (TG, 1 µM), or TG plus TUDCA.
Consistent with reports involving other cell lines [19], TG treatment caused a marked decrease in
cell viability compared to that of control cells, while TUDCA counteracted this detrimental change
(Figure 6A). ER stress can induce apoptotic cell death [11], so we used TUNEL assay to detect
apoptotic cells in control, TG, and TG plus TUDCA treated cells. The number of apoptotic cells was
markedly increased in TG-treated cells compared to control cells, while the number was significantly
decreased in cells exposed to TG-plus-TUDCA compared to cells exposed to TG alone (Figure 6B,C).
CCAAT-enhancer-binding protein homologous protein (CHOP) plays a critical role in mediating
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ER stress-induced apoptotic cell death. Being a transcription factor, CHOP can directly upregulate
tribbles homolog 3 (TRB3) expression and subsequently inhibit protein kinase B activation, leading
to apoptosis [23,24]. We measured CHOP expression in control, TG, and TG-plus-TUDCA-treated
cells by qRT-PCR. CHOP expression was significantly increased in TG-treated cells at the mRNA level
compared to control cells. TUDCA co-treatment significantly decreased CHOP expression compared
to cells treated with TG only (Figure 7A). Activated IRE1 can induce XBP1 splicing and produce
spliced XBP1, which subsequently upregulates Bip expression, and therefore, is also an indicator of ER
stress [11,25]. We found that Spliced XBP1 was significantly increased in TG-treated cells compared to
that of untreated cells, while it was markedly decreased in TUDCA plus TG exposed cells compared to
cells exposed to TG alone (Figure 7B).
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Figure 6. TUDCA counteracted the effects of thapsigargin (TG, 1µM) on ARPE-19 cell viability and
apoptotic cell death. (A) Cell viability was examined using an MTT assay. (B) Apoptotic cells in control,
TG, and TG-plus-TUDCA-treated cells were detected by TUNEL assay; nuclei were labeled with DAPI
(scale bar, 10 µM). (C) The apoptotic cell rate in untreated (UT) control and treated cells was quantified.
Data are shown as mean ± SEM. Ns, no significance, TUDCA vs. UT; **** p < 0.0001, 1 µM TG vs. UT;
#### p < 0.0001, 1 µM TG plus TUDCA vs. 1 µM TG.
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4. Discussion
Oxidative and ER stress plays a critical role in the progression of inherited and complex retinal
degeneration, e.g., retinitis pigmentosa and AMD [2,11,26]. Suppression of oxidative and ER stress
represents a promising therapeutic strategy for the treatment of retinal degeneration. As such, it would
be of clear benefit to developing products that protect against oxidative and ER stress. TUDCA is
one such product that is known to offer protection against retinal degeneration [6]. However, the
underlying protective mechanisms are not well elucidated. Our current study demonstrated that
TUDCA attenuated cell death, decreased ROS production, upregulated antioxidant gene expression,
and inhibited inflammation in H2O2-treated RPE cells. TUDCA treatment also suppressed TG-induced
ER stress and associated cell death.
TUDCA can prevent apoptotic cell death via inhibiting Bax translocation, cytochrome c release,
and caspase activation [27]. Previous studies have shown that TUDCA inhibits retinal cell death
by counteracting oxidative stress [28]. Gaspar et al. (2013) reported that TUDCA attenuated retinal
neural cell death and decreased ROS production and protein oxidation induced by a high glucose
concentration (30 mM) [29]. In a retinal detachment rat model, TUDCA prevented photoreceptor
degeneration via decreasing oxidative stress and caspase activities [30]. Intense light can cause
oxidative damage, resulting in photoreceptor degeneration. TUDCA treatment significantly reduced
superoxide radicals, decreased photoreceptor death, and increased visual function in the retinas of mice
treated with intense light [3,9]. A recent study reported that TUDCA preserved cone photoreceptors
and visual function in n-methyl-n-nitrosourea-induced mouse retinal degeneration by suppressing
the expression of apoptotic factors (caspase 3, calpain-2, and Bax), increasing SOD protein level, and
reducing MDA formation [31]. In our current study, the data demonstrated that TUDCA also alleviated
H2O2-induced oxidative damage in RPE cells. TUDCA treatment prevented caspase 3-dependent RPE
apoptosis, indicated by a decrease in both caspase 3 expression and caspase 3/7 activities (Figure 1C,D,
and Figure 2). It is possible, of course, that TUDCA might attenuate other H2O2-induced cell death
pathways that were not examined. TUDCA treatment also enhanced antioxidant capacity in RPE
cells exposed to H2O2 by upregulating antioxidant gene expression, increasing antioxidant enzyme
activities and GSH level, and inhibiting MDA production (Figures 3 and 4). Transcription factor
NRF2, is a key regulator for antioxidant gene expression and plays a beneficial role in retinal cell
protection against oxidative damage [2]. Loss of NRF2 in mice causes age-related RPE atrophy,
choroidal neovascularization, and sub-RPE deposition [32]. Early studies demonstrated that TUDCA
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suppressed rifampicin-induced damage in HepG2 cells via upregulating expression of NRF2 at mRNA
and protein levels [33]. TUDCA also increased NRF2 protein level in the midbrain and striatum of
mice challenged with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP); subsequently, expression
and activities of antioxidant enzymes, the downstream targets of NRF2, were also increased in
MPTP-injected mouse midbrain and striatum with TUDCA treatment [34]. Our current work showed
that TUDCA upregulated NRF2 expression at the mRNA level in RPE cells (Figure S1) and also
increased the expression and activities of NRF2 downstream target antioxidant enzymes (Figure 3B–F
and Figure 4A,B).
Inflammation plays a key role in the progression of retinal degeneration [22]. Protection by
TUDCA against inflammation has been shown in animals with different types of diseases, such as
hepatic ischemia-reperfusion and acute neuroinflammation [28]. TUDCA has been demonstrated to
have anti-inflammatory activity in the retinas of streptozotocin-induced diabetic rats by suppressing
the expression of intercellular adhesion molecule 1 (ICAM-1), nitric oxide synthase (NOS), nuclear
factor kappa-light-chain-enhancer of activated B cells (NF-κB) P65, and vascular endothelial growth
factor (VEGF) [35]. Choroidal neovascularization (CNV) is one of the clinical features of AMD, the
commonest cause of visual impairment in the aged population [2]. Laser-induced CNV formation
in rats was suppressed by TUDCA treatment through its anti-inflammatory action [36]. In inherited
retinal degeneration (retinitis pigmentosa, RP), TUDCA prevented photoreceptor degeneration in rpgr
knockout mice, an RP mouse model. TUDCA also ameliorated microglial activation and infiltration to
the photoreceptor layer [14]. Activated microglia can produce proinflammatory cytokines, e.g., IL-1β
and TNF-α, and TUDCA treatment suppressed inflammasome formation and decreased IL-1β
production in the rpgr knockout mouse retinas [14]. TUDCA also preserves retinal function in
RHOP23H/P23H transgenic rats, another RP model, through the inhibition of microglial activation [8,37].
Our current study also showed that TUDCA alleviated H2O2-induced inflammation in RPE cells,
decreasing expression and secretion of proinflammatory cytokines, IL-1β, IL-6, and TNF-α (Figure 5),
which may help to maintain RPE function and benefit photoreceptor cells. In fact, a previous study has
shown that TUDCA reverses H2O2-induced phagocytosis impairment in RPE cells by activating the
MerTK pathway [38], which may contribute to the prevention of photoreceptor degeneration under
stress condition.
ER stress is caused by an abnormal build-up of unfolded and misfolded proteins in the ER,
which results in the activation of the unfolded protein response (UPR). UPR is mediated by the PERK,
IRE1, and ATF6 signal pathways. When these pathways are activated, biosynthesis of unfolded or
misfolded proteins is decreased, biosynthesis of chaperones is increased, and proteasome-mediated
protein degradation is activated. Under severe ER stress, UPR activates an apoptotic process by
upregulating the expression of CHOP [11,28]. TUDCA has been shown to exert chaperoning activity by
promoting protein trafficking and increasing protein folding capacity via ATF6 activation. Abundant
evidence has demonstrated that TUDCA alleviates ER stress in different cell types and disease
animal models [27]. TUDCA also can inhibit ER stress-associated apoptosis through modulating
intracellular calcium levels and blocking the activation of calpain and caspase-12 [27]. Mutation in
the cyclic nucleotide-gated channel alpha subunit (CNGA3) gene causes achromatopsia 3 with cone
dysfunction [38]. Overexpressed CNGA3 mutant proteins (CNGA3R563H and CNGA3Q655X) were
no longer localized to the plasma membrane and were retained in the ER, causing ER stress in
photoreceptor 661W cells with higher XBP1 splicing and expression of Bip and CHOP; TUDCA
treatment alleviated CNGA3 mutant protein-associated ER stress, enhanced the mutant protein’s cell
surface localization and reduced ER retention [39]. TUDCA also preserved cone photoreceptor function
in lrat-/- mice, a model for Leber congenital amaurosis (LCA) and early retinal dystrophy, through the
reduction of ER stress and apoptosis. Mice treated with TUDCA had decreased CHOP protein and
caspase activities in their retinas [40]. Our current data also demonstrated that TUDCA attenuated
TG-induced ER stress and apoptosis in RPE cells, in which CHOP and spliced XBP1 expression was
significantly reduced (Figures 6 and 7).
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Our observation here was based on an in vitro non-polarized RPE cell model, which might not be
exactly relevant to an in vivo study. Ideally, we can further examine the protection of TUDCA against
oxidative and ER stress in polarized ARPE-19 and primary RPE cells and in preclinical models to
fully verify the observation made. In addition, it would be important to gain more insights into the
molecular mechanism of TUDCA’s protection in vivo.
5. Conclusions
Our work demonstrates that TUDCA can protect RPE from oxidative stress, inflammation, and
ER stress, and further supports that TUDCA has therapeutic potential for treating retinal degeneration.
Supplementary Materials: The following are available online at http://www.mdpi.com/2227-9059/8/9/367/s1,
Figure S1: Protection of TUDCA against oxidative damage was mediated by NRF2. NRF expression in control,
H2O2, and H2O2-plus-TUDCA-treated cells was measured by qRT-PCR, Table S1: Primers for qRT-PCT.
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